Phase I dose-escalation study of talimogene laherparepvec (T-VEC) for advanced pancreatic cancer (ca).
Kenneth J. Chang
No relevant relationships to disclose
Neil N. Senzer
No relevant relationships to disclose
Kenneth Binmoeller
No relevant relationships to disclose
Howard Goldsweig
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Robert Coffin
Consultant or Advisory Role - Amgen
Stock Ownership - Amgen